14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
AETH vs INSP: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
INSP Overall Winner
6-Pillar Tally: AETH 0 – 6 INSP
Matrix Metrics: AETH 3 – 7 INSP
As of Nov 20, 2026, Inspire Medical Systems, Inc. (INSP) is the stronger overall head-to-head candidate over Bitwise Trendwise Ether and Treasuries Rotation Strategy ETF (AETH) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AETH carries a Unified Composite Score of 56.5/100 (HOLD) at $37.54 (N/M Forward P/E, N/A operating margin), whereas INSP carries 52.5/100 (HOLD) at $55.10 (36.9x Forward P/E, 4.5% operating margin).
Composite vs. Pillar Nuance: While AETH currently prints a higher short-term Unified Composite Score (56.5/100 HOLD vs. INSP 52.5/100 HOLD), INSP captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (4.5% vs. N/A operating margin) and revenue trajectory (-7.9% vs. N/A YoY).
Technical & Structure Timing Caution: AETH trades in a Markup technical trend (SURGE options phase, RSI 54.2); meanwhile INSP is in a Breakdown options structure phase (RSI 27.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AETH vs INSP. Trailing 12-month operating profitability (AETH N/A vs INSP 4.5%) and valuation multiples (AETH N/M vs INSP 36.9x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Devices value chain with $1.6B market capitalization and 4.5% operating margin.
OpEx & R&D Reinvestment81.7% of Rev ($720M)
90D Engineering Disclosures0 Published
Investor FAQ AETH vs INSP Key Questions & Quantitative Answers
As of Nov 20, 2026, Inspire Medical Systems, Inc. (INSP) is the stronger overall head-to-head candidate over Bitwise Trendwise Ether and Treasuries Rotation Strategy ETF (AETH) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AETH carries a Unified Composite Score of 56.5/100 (HOLD) at $37.54 (N/M Forward P/E, N/A operating margin), whereas INSP carries 52.5/100 (HOLD) at $55.10 (36.9x Forward P/E, 4.5% operating margin). Composite vs. Pillar Nuance: While AETH currently prints a higher short-term Unified Composite Score (56.5/100 HOLD vs. INSP 52.5/100 HOLD), INSP captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (4.5% vs. N/A operating margin) and revenue trajectory (-7.9% vs. N/A YoY). Technical & Structure Timing Caution: AETH trades in a Markup technical trend (SURGE options phase, RSI 54.2); meanwhile INSP is in a Breakdown options structure phase (RSI 27.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
INSP leads the Growth & Scale pillar: AETH posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with INSP at -7.9% YoY revenue growth and +308.4% YoY earnings growth on $881M TTM revenue (86.2% gross margin, 4.5% operating margin). On trailing 12-month operating scale, AETH generates N/A in USD-normalized revenue versus $881M for INSP. In operating R&D and SG&A reinvestment, AETH deploys N/A (0 90-day corporate R&D disclosures) versus 81.7% of Rev ($720M) (0 disclosures) for INSP.
INSP screens cheaper on headline valuation multiples. AETH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas INSP trades at 36.9x Forward P/E, 16.8x Trailing P/E, N/M PEG, and 1.7x EV/Revenue (11.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AETH (N/A ROE) versus INSP (13.5% ROE) capital efficiency.
In options market volatility and institutional positioning, AETH carries 9.5% implied volatility (1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (0.96β · 29% Vol realized risk). By comparison, INSP carries 53.2% implied volatility (7th %ile, Compressed (<25th %ile)), a 69.97x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.74β · 46% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.